ABL1 and breast carcinoma: Thus, although a number of oncogenic functions have clearly been attributed to c-Abl in human breast cancers,3, 4, 5, 6, 7, 8 we and others have observed activation of c-Abl to serve as an essential suppressor of breast cancer progression,9, 10, 11 particularly their acquisition of EMT and metastatic phenotypes.